Cargando…

Mutagenic Assessment of Olmesartan Cilexetil by Bacterial Mutation Assay

Hypertension is a serious health problem due to high frequency and concomitant other diseases including cardiovascular and renal dysfunction. Olmesartan cilexetil is a new antihypertensive drug associated with angiotensin II receptor antagonist. This study was conducted to evaluate the mutagenicity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ji Won, Ahn, Ilyoung, Ryu, Sung Ha, Jeon, Hong Ryeol, Lee, Bong Sang, Kim, Kyu-Bong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Toxicology 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878002/ https://www.ncbi.nlm.nih.gov/pubmed/24386523 http://dx.doi.org/10.5487/TR.2013.29.3.217

Ejemplares similares

Mutagenicity of Flavonoids Assayed by Bacterial Reverse Mutation (Ames) Test
por: Resende, Flavia Aparecida, et al.
Publicado: (2012)

Candesartan cilexetil in the treatment of chronic heart failure
por: Baguet, Jean-Philippe, et al.
Publicado: (2009)

Candesartan cilexetil: COVID-19 pneumonia: case report
Publicado: (2020)

Repurposing Candesartan Cilexetil as Antibacterial Agent for MRSA Infection
por: Xu, Lanlan, et al.
Publicado: (2021)

Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T)
por: Bönner, Gerd, et al.
Publicado: (2011)

Mutagenic activity of phthalate esters in bacterial liquid suspension assays.
por: Seed, J L
Publicado: (1982)

Design and development and evaluation of candesartan cilexetil liquid filling formulations
por: Deepthi, Y., et al.
Publicado: (2015)

Development of Orodispersible Tablets of Candesartan Cilexetil-β-cyclodextrin Complex
por: Sravya, Maddukuri, et al.
Publicado: (2013)

The Effect of Polysorbate 20 on Solubility and Stability of Candesartan Cilexetil in Dissolution Media
por: Hoppe, Katarzyna, et al.
Publicado: (2014)

Applying Different Techniques to Improve the Bioavailability of Candesartan Cilexetil Antihypertensive Drug
por: Aly, Usama Farghaly, et al.
Publicado: (2020)

Formulation and Bioavailability of Novel Mucoadhesive Buccal Films for Candesartan Cilexetil in Rats
por: Mady, Omar Y., et al.
Publicado: (2021)

Chemometric Methods for Simultaneous Determination of Candesartan Cilexetil and Hydrochlorothiazide in Binary Combinations
por: Ali, Diyar Salahuddin
Publicado: (2023)

Four-Week Repeated Oral Toxicity Study of AIP1, a Water-soluble Carbohydrate Fraction from Artemisia iwayomogi in Mice
por: Ryu, Sung Ha, et al.
Publicado: (2011)

Mutagenicity assessment of Salacia chinensis by bacterial reverse mutation assay using histidine dependent Salmonella typhimurium tester strains
por: Reddi Nagesh, Madhuranthakam, et al.
Publicado: (2022)

Enhanced Antihypertensive Activity of Candesartan Cilexetil Nanosuspension: Formulation, Characterization and Pharmacodynamic Study
por: Detroja, Chetan, et al.
Publicado: (2011)

Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study
por: Baguet, JP, et al.
Publicado: (2009)

Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool
por: Figueroa-Campos, Andrés, et al.
Publicado: (2020)

Enteropathy Associated with Olmesartan
por: Silva, Bruno Moreira da, et al.
Publicado: (2015)

Testing the environment for dispersed mutagens: use of plant bioconcentrators coupled with microbial mutagen assays.
por: Barnes, W S, et al.
Publicado: (1978)

Development and characterization of controlled release polar lipid microparticles of candesartan cilexetil by solid dispersion
por: Kamalakkannan, V, et al.
Publicado: (2013)

Statistical analysis of data in mutagenicity assays: rodent micronucleus assay.
por: Hayashi, M, et al.
Publicado: (1994)

Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study
por: Martinez-Martin, F J, et al.
Publicado: (2011)

Mutagenic cost of ribonucleotides in bacterial DNA
por: Schroeder, Jeremy W., et al.
Publicado: (2017)

Developing pH-Modulated Spray Dried Amorphous Solid Dispersion of Candesartan Cilexetil with Enhanced In Vitro and In Vivo Performance
por: Poudel, Surendra, et al.
Publicado: (2021)

Mutagenic properties of dimethylaniline isomers in mice as evaluated by comet, micronucleus and transgenic mutation assays
por: Kohara, Arihiro, et al.
Publicado: (2018)

Mutagenic metabolites of benzene detected in the Microscreen assay.
por: Rossman, R G, et al.
Publicado: (1989)

Olmesartan: Induced maculopapular rash
por: Bhushan, Aruna, et al.
Publicado: (2013)

Enteropatía secundaria a olmesartán
por: Curieses Luengo, María, et al.
Publicado: (2017)

Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility
por: Mengden, Thomas, et al.
Publicado: (2009)

Bioequivalence study of two formulations of candesartan cilexetil tablet in healthy subjects under fasting conditions
por: Tjandrawinata, Raymond R, et al.
Publicado: (2013)

Nephroprotective effects of Candesartan Cilexetil against Cyclosporine A-induced nephrotoxicity in a rat model
por: Ghafil, Fadhaa Abdulameer, et al.
Publicado: (2022)

Subacute oral toxicity and bacterial mutagenicity study of Korean Red Ginseng oil
por: Seo, Hwi Won, et al.
Publicado: (2017)

The development and prevalidation of an in vitro mutagenicity assay based on MutaMouse primary hepatocytes, Part II: Assay performance for the identification of mutagenic chemicals
por: Cox, Julie A., et al.
Publicado: (2019)

Extracellular and intracellular anti-mutagenic effects of bile pigments in the Salmonella typhimurium reverse mutation assay
por: Mölzer, C., et al.
Publicado: (2013)

The use of bacterial mutagenicity tests in carcinogenicity studies.
por: Venitt, S.
Publicado: (1980)

Screening aquatic ecosystems for mutagens with fern bio-assays
por: Klekowski, Edward J.
Publicado: (1978)

Mutagenicity of PCBs and their pyrosynthetic derivatives in cell-mediated assay.
por: Hattula, M L
Publicado: (1985)

Pharmacokinetics and bioequivalence of fixed-dose combination of candesartan cilexetil/amlodipine besylate (16/10 mg) versus coadministration of individual formulations in healthy subjects
por: Lee, Hae Won, et al.
Publicado: (2020)

The Anti-inflammatory Compound Candesartan Cilexetil Improves Neurological Outcomes in a Mouse Model of Neonatal Hypoxia
por: Quinlan, Sean, et al.
Publicado: (2019)

Immunoglobulin G4-Related Inflammatory Pseudotumor Presenting as a Solitary Mass in the Stomach
por: Cheong, Hong Ryeol, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_356i6q4fb7r81staesl7jimjvt